4/A
Changes in Ownership
Faeth Therapeutics, Inc. Filed Acc 0001209191-23-021540
Chief Business Officer acquired 43,513 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gallagher Patrick Stephen Chief Business Officer | 2023-02-15 | Grant or award | +29,313 | 29,313 | D | ||
| Gallagher Patrick Stephen Chief Business Officer | 2023-02-15 | Grant or award | +14,200 | 43,513 | D | ||
| Derivatives | |||||||
| Gallagher Patrick Stephen Chief Business Officer | 2023-02-15 | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | D | ||
Loading xslF345X04/doc4a.xml…